Keywords: Genzyme, ChemRar, Russia, Orpohan drug, Rare diseases, Vaccines, R&D

Genzyme in orphan drug collaboration with Russia’s ChemRar

Article | 28 March 2011

Print This

US biotech Genzyme (Nasdaq: GENZ), the subject of a takeover by French drug major Sanofi-Aventis, has signed an agreement with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in